Next Article in Journal
New Aspects of Vitamin K Research with Synthetic Ligands: Transcriptional Activity via SXR and Neural Differentiation Activity
Next Article in Special Issue
Sex- and Age-Related Estrogen Signaling Alteration in Inflammatory Bowel Diseases: Modulatory Role of Estrogen Receptors
Previous Article in Journal
Myeloid-Specific Deletion of the AMPKα2 Subunit Alters Monocyte Protein Expression and Atherogenesis
Previous Article in Special Issue
Rhododendrin-Induced RNF146 Expression via Estrogen Receptor β Activation is Cytoprotective Against 6-OHDA-Induced Oxidative Stress
Article

Novel Selective Estrogen Receptor Modulator Ameliorates Murine Colitis

1
Institute of Biomedicine, University of Turku, FI-20520 Turku, Finland
2
Faculty of Science and Engineering, Department Biosciences, Cell Biology; Åbo Akademi University, FI-20520 Turku, Finland
3
Forendo Pharma Ltd., FI-20520 Turku, Finland
4
Turku Center for Disease Modeling, FI-20520 Turku, Finland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(12), 3007; https://doi.org/10.3390/ijms20123007
Received: 22 May 2019 / Revised: 14 June 2019 / Accepted: 18 June 2019 / Published: 20 June 2019
(This article belongs to the Special Issue Molecular Pathways of Estrogen Receptor Action 2.0)
Estrogen-receptor-mediated signaling has been suggested to decrease the inflammatory response in monocyte macrophages. Previously, we showed that a novel selective estrogen receptor modulator (SERM2) promotes anti-inflammatory phenotype of monocytes in vitro. In this study, we demonstrate the potential of SERM2 in amelioration of colitis. We utilized a dextran sodium sulfate (DSS)-induced colitis model in FVB/n mice to demonstrate the effects of orally administered SERM2 on the clinical status of the mice and the histopathological changes in the colon, as well as proportion of Mrc-1 positive macrophages. SERM2 nuclear receptor affinities were measured by radioligand binding assays. Orally administered, this compound significantly alleviated DSS-induced colitis in male mice and induced local estrogen receptor activation in the inflamed colon, as well as promoting anti-inflammatory cytokine expression and infiltration of anti-inflammatory monocytes. We show that this novel drug candidate has an affinity to estrogen receptors α and β and progesterone receptors, but not to glucocorticoid receptor, thus expressing unique binding properties compared to other sex steroid receptor ligands. These results indicate that novel drug candidates to alleviate inflammatory conditions of the colon could be found among sex steroid receptor activating compounds. View Full-Text
Keywords: colitis; selective estrogen receptor modulator; estrogen receptor; progesterone receptor; inflammation; macrophages colitis; selective estrogen receptor modulator; estrogen receptor; progesterone receptor; inflammation; macrophages
Show Figures

Graphical abstract

MDPI and ACS Style

Polari, L.; Anttila, S.; Helenius, T.; Wiklund, A.; Linnanen, T.; Toivola, D.M.; Määttä, J. Novel Selective Estrogen Receptor Modulator Ameliorates Murine Colitis. Int. J. Mol. Sci. 2019, 20, 3007. https://doi.org/10.3390/ijms20123007

AMA Style

Polari L, Anttila S, Helenius T, Wiklund A, Linnanen T, Toivola DM, Määttä J. Novel Selective Estrogen Receptor Modulator Ameliorates Murine Colitis. International Journal of Molecular Sciences. 2019; 20(12):3007. https://doi.org/10.3390/ijms20123007

Chicago/Turabian Style

Polari, Lauri, Santeri Anttila, Terhi Helenius, Anu Wiklund, Tero Linnanen, Diana M. Toivola, and Jorma Määttä. 2019. "Novel Selective Estrogen Receptor Modulator Ameliorates Murine Colitis" International Journal of Molecular Sciences 20, no. 12: 3007. https://doi.org/10.3390/ijms20123007

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop